CefoBio Co

Overview

Updated: Sep 4, 2026

Company Overview

A regenerative medicine biotech commercializing musculoskeletal cell therapies and biomaterials on a proprietary 3D hydrogel platform

Address

Headquarters :Room 1310, Building D, SK Techno Park, 60, Haan-ro, Gwangmyeong-si,

Research Center :-

Website

https://cefobio.com/

Class

Medical Technology

Type

Rehabilitation

Indications

Osteonecrosis ofthe Femoral Head

Partnering Goals

Private

Investment Info

Investment History

Total USD 7M 500K

2021-2023
7.5M
Investor Amount
SV,Mirae, KAI, etc 7.5M

Investor	Amount
SV,Mirae, KAI, etc	7.5M

Shareholders

VCs

Hyun-Sook Park

Chang-Gon Kwak

Funding Goal

Target StageSeries C

Target Amount7.5M

Funding Purpose

+ CF-M801 Phase 2 clinical trial + Europe, Japan, and US global clinical trials + R&D·L/O·GMP Scale-up

Team

Key People

CEO

HyunSuk Park

Head of R&D

Sunray Lee

Advisors

Private

Tech & Products

Technology Details

3D Cell Navigator

3D cell differentiation platform technology using synthetic biogel

Cell Growth Medium

for optimized cell growth

Problem & Unmet Needs

Osteonecrosis of the Femoral Head (ONFH): An unmet medical need with limited fundamental treatment options to suppress disease progression and femoral head collapse

Market Trends

A disease with large global market potential— approximately 20,000-30,000 new patients occur annually in the US, with a large patient population also reported in China

Competitive Landscape

Private

Pipeline

CF-M801

Current Stage

Phase 2

CandidateNon clinicalPhase 1Phase 2Phase 3Authorization

Pipeline

DR-NK

Current Stage

Phase 1

CandidateNon clinicalPhase 1Phase 2Phase 3Authorization

Patents & Papers

Papers

Private

Patents

Patent Title

Osteoblasts Differentiated from Mesenchymal Stem Cells and Composition for Treating Bone Disease Comprising Same

Status

등록

Application Year

Private

Application Countries

KR/CN/JP

Patent Title

Three-Dimensional Cell Culture System and Cell Culture Method Using Same

Status

등록

Application Year

Private

Application Countries

KR/US/GB

Patent Title

Method for Inducing Three-Dimensional Osteogenic Differentiation of Stem Cells Using Hydrogel

Status

등록

Application Year

Private

Application Countries

KR/US/JP/CN

Certifications

Private

Latest News

Private